Respiratory illness trial boosts Cynata share price today
MELBOURNE: Shares in stem cell biotech Cynata Therapeutics have jumped 4.3 per cent, with the
MELBOURNE: Shares in stem cell biotech Cynata Therapeutics have jumped 4.3 per cent, with the